InvestorsHub Logo
Followers 4
Posts 91
Boards Moderated 0
Alias Born 12/17/2020

Re: DewDiligence post# 39357

Monday, 06/28/2021 7:59:49 PM

Monday, June 28, 2021 7:59:49 PM

Post# of 43714
Multikine did better than SOC in all scenarios afaik. Simply, it did not meet the target in the scenario with the chemotherapy, which makes absolute sense. Multikine is incompatible with chemotherapy. This will be the case with all immunotherapy treatments, including DCvax from NWBO. Somehow I think this incompatibility has been overlooked when defining the case study and that is unfortunate.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News